Copyright
©The Author(s) 2018.
World J Orthop. Mar 18, 2018; 9(3): 14-23
Published online Mar 18, 2018. doi: 10.5312/wjo.v9.i3.14
Published online Mar 18, 2018. doi: 10.5312/wjo.v9.i3.14
Table 1 Sacroiliac joint range of motion for an intact model and 22 configurations of implant orientation, superior implant length, and number of implants
Treatment/orientation | Implant placed | Superior implant ending point | SI joint ROM (°) [Reduction in ROM (%)] | ||||
Superior | Middle | Inferior | Flexion-extension | Lateral bending | Axial rotation | ||
Intact | - | - | - | -1 | 1.94° (-) | 0.66° (-) | 1.11° (-) |
Inline orientation | X | X | X | Mid-ala | 0.7° (64%) | 0.45° (32%) | 0.41° (63%) |
Mid-sacrum | 0.63° (68%) | 0.41° (38%) | 0.38° (66%) | ||||
X | - | X | Mid-ala | 0.82° (58%) | 0.47° (29%) | 0.44° (60%) | |
Mid-sacrum | 0.69° (64%) | 0.43° (35%) | 0.4° (64%) | ||||
X | X | - | Mid-ala | 0.97° (50%) | 0.5° (24%) | 0.49° (56%) | |
Mid-sacrum | 0.76° (61%) | 0.45° (32%) | 0.43° (61%) | ||||
- | X | X | -1 | 0.91° (53%) | 0.53° (20%) | 0.55° (50%) | |
X | - | - | Mid-ala | 1.36° (30%) | 0.58° (12%) | 0.67° (40%) | |
Mid-sacrum | 1.21° (38%) | 0.58° (12%) | 0.61° (45%) | ||||
- | X | - | -1 | 1.32° (32%) | 0.65° (2%) | 0.73° (34%) | |
- | - | X | -1 | 1.25° (36%) | 0.69° (-5%) | 0.79° (29%) | |
Transarticular orientation | X | X | X | Mid-ala | 0.59° (70%) | 0.41° (38%) | 0.34° (69%) |
Mid-sacrum | 0.52° (73%) | 0.38° (42%) | 0.31° (72%) | ||||
X | - | X | Mid-ala | 0.69° (64%) | 0.42° (36%) | 0.36° (68%) | |
Mid-sacrum | 0.58° (70%) | 0.39° (41%) | 0.32° (71%) | ||||
X | X | - | Mid-ala | 0.81° (58%) | 0.45° (32%) | 0.4° (64%) | |
Mid-sacrum | 0.64° (67%) | 0.41° (38%) | 0.35° (68%) | ||||
- | X | X | -1 | 0.76° (61%) | 0.47° (29%) | 0.46° (59%) | |
X | - | - | Mid-ala | 1.36° (30%) | 0.58° (12%) | 0.67° (40%) | |
Mid-sacrum | 1.21° (38%) | 0.58° (12%) | 0.61° (45%) | ||||
- | X | - | -1 | 1.11° (43%) | 0.6° (9%) | 0.7° (37%) | |
- | - | X | -1 | 1.05° (46%) | 0.62° (6%) | 0.73° (34%) |
Table 2 Reduction in sacroiliac joint range of motion (°) between transarticular and inline orientation groups
Orientation | Implants (positions) | Superior implant ending point | Reduction in SI joint ROM (°) (%) | ||
Flexion-extension | Lateral bending | Axial rotation | |||
Transarticular vs inline | 3 (S, M, I) | Mid-ala | 0.11° (16%) | 0.04° (9%) | 0.07° (17%) |
Mid-sacrum | 0.11° (17%) | 0.03° (7%) | 0.07° (18%) | ||
2 (S, -, I) | Mid-ala | 0.13° (16%) | 0.05° (11%) | 0.08° (18%) | |
Mid-sacrum | 0.11° (16%) | 0.04° (9%) | 0.08° (20%) | ||
2 (S, M, -) | Mid-ala | 0.16° (16%) | 0.05° (10%) | 0.09° (18%) | |
Mid-sacrum | 0.12° (16%) | 0.04° (9%) | 0.08° (19%) | ||
2 (-, M, I) | -1 | 0.15° (16%) | 0.06° (11%) | 0.09° (16%) | |
1 (-, M, -) | -1 | 0.21° (16%) | 0.05° (8%) | 0.03° (4%) | |
1 (-, -, I) | -1 | 0.20° (16%) | 0.07° (10%) | 0.06° (8%) | |
Median (°) (Range) | 0.13° (0.11-0.21) | 0.05° (0.03-0.07) | 0.08° (0.03-0.09) | ||
Median (%) (Range) | 16% (16-17) | 9% (7-11) | 18% (4-20) |
Table 3 Reduction in sacroiliac joint range of motion (°) between mid-sacrum and mid-ala placement groups
Reduction in SI joint ROM (°) (%) | |||||
Superior implant ending point | Orientation | Implants (position) | Flexion-extension | Lateral bending | Axial rotation |
Mid-sacrum vs mid-ala | Inline | 3 (S, M, I) | 0.07° (10%) | 0.04° (9%) | 0.03° (7%) |
2 (S, -, I) | 0.13° (16%) | 0.04° (9%) | 0.04° (9%) | ||
2 (S, M, -) | 0.21° (22%) | 0.05° (10%) | 0.06° (12%) | ||
1 (S, -, -) | 0.15° (11%) | 0.00° (0%) | 0.06° (9%) | ||
Trans-articular | 3 (S, M, I) | 0.07° (12%) | 0.03° (7%) | 0.03° (9%) | |
2 (S, -, I) | 0.11° (16%) | 0.03° (7%) | 0.04° (11%) | ||
2 (S, M, -) | 0.17° (21%) | 0.04° (9%) | 0.05° (13%) | ||
1 (S, -, -) | 0.15° (11%) | 0.00° (0%) | 0.06° (9%) | ||
Median (°) (Range) | 0.14° (0.07-0.21) | 0.035° (0.00-0.05) | 0.045° (0.03-0.06) | ||
Median (%) (Range) | 14% (10-22) | 8% (0-10) | 9% (7-13) |
Table 4 Change in sacroiliac joint flexion-extension range of motion (°) as a result of reducing the number of implants
Treatment | Implants (positions) | Superior implant ending point | Range of motion (°) | Motion increase (°) | % 3 Implant motion |
Intact | - | -1 | 1.94 | - | - |
Inline | 3 (S, M, I) | Mid-ala | 0.7 | Reference configuration | |
Inline | 2 (S, M, -) | Mid-ala | 0.97 | 0.27 | 39 |
Inline | 2 (S, -, I) | Mid-ala | 0.82 | 0.12 | 17 |
Inline | 2 (-, M, I) | -1 | 0.91 | 0.21 | 30 |
Inline | 1 (S, -, -) | Mid-ala | 1.36 | 0.66 | 94 |
Inline | 1 (-, M, -) | -1 | 1.32 | 0.62 | 89 |
Inline | 1 (-, -, I) | -1 | 1.25 | 0.55 | 79 |
Inline | 3 (S, M, I) | Mid-sacrum | 0.63 | Reference configuration | |
Inline | 2 (S, M, -) | Mid-sacrum | 0.76 | 0.13 | 21 |
Inline | 2 (S, -, I) | Mid-sacrum | 0.69 | 0.06 | 10 |
Inline | 1 (S, -, -) | Mid-sacrum | 1.21 | 0.58 | 92 |
Transarticular | 3 (S, M, I) | Mid-ala | 0.59 | Reference configuration | |
Transarticular | 2 (S, M, -) | Mid-ala | 0.81 | 0.22 | 37 |
Transarticular | 2 (S, -, I) | Mid-ala | 0.69 | 0.1 | 17 |
Transarticular | 2 (-, M, I) | -1 | 0.76 | 0.17 | 29 |
Transarticular | 1 (S, -, -) | Mid-ala | 1.36 | 0.77 | 131 |
Transarticular | 1 (-, M, -) | -1 | 1.11 | 0.52 | 88 |
Transarticular | 1 (-, -, I) | -1 | 1.05 | 0.46 | 78 |
Transarticular | 3 (S, M, I) | Mid-sacrum | 0.52 | Reference configuration | |
Transarticular | 2 (S, M, -) | Mid-sacrum | 0.64 | 0.12 | 23 |
Transarticular | 2 (S, -, I) | Mid-sacrum | 0.58 | 0.06 | 12 |
Transarticular | 1 (S, -, -) | Mid-sacrum | 1.21 | 0.69 | 133 |
Treatment | Implants (positions) | Superior implant ending point | % 3 Implant motion | Implants (positions) | Median (%) [range] |
Inline | 2 (S, -, I) | Mid-ala | 17 | 2 (S, -, I) | 14.5% (10-17) |
Inline | 2 (S, -, I) | Mid-sacrum | 10 | ||
Transarticular | 2 (S, -, I) | Mid-ala | 17 | ||
Transarticular | 2 (S, -, I) | Mid-sacrum | 12 | ||
Inline | 2 (S, M, -) | Mid-ala | 39 | 2 (S, M, -) | 30% (21-39) |
Inline | 2 (S, M, -) | Mid-sacrum | 21 | ||
Transarticular | 2 (S, M, -) | Mid-ala | 37 | ||
Transarticular | 2 (S, M, -) | Mid-sacrum | 23 | ||
Inline | 2 (-, M, I) | -1 | 30 | 2 (-, M, I) | 29.5% (29-30) |
Transarticular | 2 (-, M, I) | -1 | 29 | ||
Inline | 1 (S, -, -) | Mid-ala | 94 | 1 (S, -, -) | 112.5% (92-133) |
Inline | 1 (S, -, -) | Mid-sacrum | 92 | ||
Transarticular | 1 (S, -, -) | Mid-ala | 131 | ||
Transarticular | 1 (S, -, -) | Mid-sacrum | 133 | ||
Inline | 1 (-, M, -) | -1 | 89 | 1 (-, M, -) | 88.5% (88-89) |
Transarticular | 1 (-, M, -) | -1 | 88 | ||
Inline | 1 (-, -, I) | -1 | 79 | 1 (-, -, I) | 78.5% (78-79) |
Transarticular | 1 (-, -, I) | -1 | 78 |
Table 5 Change in sacroiliac joint lateral bending range of motion (°) as a result of reducing the number of implants
Treatment | Implants (positions) | Superior implant ending point | Range of motion (°) | Motion increase (°) | % 3 implant motion |
Intact | - | -1 | 0.66 | - | - |
Inline | 3 (S, M, I) | Mid-ala | 0.45 | Reference configuration | |
Inline | 2 (S, M, -) | Mid-ala | 0.5 | 0.05 | 11 |
Inline | 2 (S, -, I) | Mid-ala | 0.47 | 0.02 | 4 |
Inline | 2 (-, M, I) | -1 | 0.53 | 0.08 | 18 |
Inline | 1 (S, -, -) | Mid-ala | 0.58 | 0.13 | 29 |
Inline | 1 (-, M, -) | -1 | 0.65 | 0.2 | 44 |
Inline | 1 (-, -, I) | -1 | 0.69 | 0.24 | 53 |
Inline | 3 (S, M, I) | Mid-sacrum | 0.41 | Reference configuration | |
Inline | 2 (S, M, -) | Mid-sacrum | 0.45 | 0.04 | 10 |
Inline | 2 (S, -, I) | Mid-sacrum | 0.43 | 0.02 | 5 |
Inline | 1 (S, -, -) | Mid-sacrum | 0.58 | 0.17 | 41 |
Transarticular | 3 (S, M, I) | Mid-ala | 0.41 | Reference configuration | |
Transarticular | 2 (S, M, -) | Mid-ala | 0.45 | 0.04 | 10 |
Transarticular | 2 (S, -, I) | Mid-ala | 0.42 | 0.01 | 2 |
Transarticular | 2 (-, M, I) | -1 | 0.47 | 0.06 | 15 |
Transarticular | 1 (S, -, -) | Mid-ala | 0.58 | 0.17 | 41 |
Transarticular | 1 (-, M, -) | -1 | 0.6 | 0.19 | 46 |
Transarticular | 1 (-, -, I) | -1 | 0.62 | 0.21 | 51 |
Transarticular | 3 (S, M, I) | Mid-sacrum | 0.38 | Reference configuration | |
Transarticular | 2 (S, M, -) | Mid-sacrum | 0.41 | 0.03 | 8 |
Transarticular | 2 (S, -, I) | Mid-sacrum | 0.39 | 0.01 | 3 |
Transarticular | 1 (S, -, -) | Mid-sacrum | 0.58 | 0.2 | 53 |
Treatment | Implants (positions) | Superior implant ending point | % 3 Implant motion | Implants (positions) | Median (%) [range] |
Inline | 2 (S, -, I) | Mid-ala | 4 | 2 (S, -, I) | 3.5% (2-5) |
Inline | 2 (S, -, I) | Mid-sacrum | 5 | ||
Transarticular | 2 (S, -, I) | Mid-ala | 2 | ||
Transarticular | 2 (S, -, I) | Mid-sacrum | 3 | ||
Inline | 2 (S, M, -) | Mid-ala | 11 | 2 (S, M, -) | 10% (8-11) |
Inline | 2 (S, M, -) | Mid-sacrum | 10 | ||
Transarticular | 2 (S, M, -) | Mid-ala | 10 | ||
Transarticular | 2 (S, M, -) | Mid-sacrum | 8 | ||
Inline | 2 (-, M, I) | -1 | 18 | 2 (-, M, I) | 16.5% (15-18) |
Transarticular | 2 (-, M, I) | -1 | 15 | ||
Inline | 1 (S, -, -) | Mid-ala | 29 | 1 (S, -, -) | 41% (29-53) |
Inline | 1 (S, -, -) | Mid-sacrum | 41 | ||
Transarticular | 1 (S, -, -) | Mid-ala | 41 | ||
Transarticular | 1 (S, -, -) | Mid-sacrum | 53 | ||
Inline | 1 (-, M, -) | -1 | 44 | 1 (-, M, -) | 45% (44-46) |
Transarticular | 1 (-, M, -) | -1 | 46 | ||
Inline | 1 (-, -, I) | -1 | 53 | 1 (-, -, I) | 52% (51-53) |
Transarticular | 1 (-, -, I) | -1 | 51 |
Table 6 Change in sacroiliac joint axial rotation range of motion (°) as a result of reducing the number of implants
Treatment | Implants (positions) | Superior implant ending point | Range of motion | Motion increase (°) | % 3 implant motion |
Intact | - | 1 | 1.11 | - | - |
Inline | 3 (S, M, I) | Mid-ala | 0.41 | Reference configuration | |
Inline | 2 (S, M, -) | Mid-ala | 0.49 | 0.08 | 20 |
Inline | 2 (S, -, I) | Mid-ala | 0.44 | 0.03 | 7 |
Inline | 2 (-, M, I) | 1 | 0.55 | 0.14 | 34 |
Inline | 1 (S, -, -) | Mid-ala | 0.67 | 0.26 | 63 |
Inline | 1 (-, M, -) | 1 | 0.73 | 0.32 | 78 |
Inline | 1 (-, -, I) | 1 | 0.79 | 0.38 | 93 |
Inline | 3 (S, M, I) | Mid-sacrum | 0.38 | Reference configuration | |
Inline | 2 (S, M, -) | Mid-sacrum | 0.43 | 0.05 | 13 |
Inline | 2 (S, -, I) | Mid-sacrum | 0.4 | 0.02 | 5 |
Inline | 1 (S, -, -) | Mid-sacrum | 0.61 | 0.23 | 61 |
Transarticular | 3 (S, M, I) | Mid-ala | 0.34 | Reference configuration | |
Transarticular | 2 (S, M, -) | Mid-ala | 0.4 | 0.06 | 18 |
Transarticular | 2 (S, -, I) | Mid-ala | 0.36 | 0.02 | 6 |
Transarticular | 2 (-, M, I) | 1 | 0.46 | 0.12 | 35 |
Transarticular | 1 (S, -, -) | Mid-ala | 0.67 | 0.33 | 97 |
Transarticular | 1 (-, M, -) | 1 | 0.7 | 0.36 | 106 |
Transarticular | 1 (-, -, I) | 1 | 0.73 | 0.39 | 115 |
Transarticular | 3 (S, M, I) | Mid-sacrum | 0.31 | Reference configuration | |
Transarticular | 2 (S, M, -) | Mid-sacrum | 0.35 | 0.04 | 13 |
Transarticular | 2 (S, -, I) | Mid-sacrum | 0.32 | 0.01 | 3 |
Transarticular | 1 (S, -, -) | Mid-sacrum | 0.61 | 0.3 | 97 |
Treatment | Implants (positions) | Superior implant ending point | % 3 Implant motion | Implants (positions) | Median (%) [range] |
Inline | 2 (S, -, I) | Mid-ala | 7 | 2 (S, -, I) | 5.5% (3-7) |
Inline | 2 (S, -, I) | Mid-sacrum | 5 | ||
Transarticular | 2 (S, -, I) | Mid-ala | 6 | ||
Transarticular | 2 (S, -, I) | Mid-sacrum | 3 | ||
Inline | 2 (S, M, -) | Mid-ala | 20 | 2 (S, M, -) | 15.5% (13-20) |
Inline | 2 (S, M, -) | Mid-sacrum | 13 | ||
Transarticular | 2 (S, M, -) | Mid-ala | 18 | ||
Transarticular | 2 (S, M, -) | Mid-sacrum | 13 | ||
Inline | 2 (-, M, I) | 1 | 34 | 2 (-, M, I) | 34.5% (34-35) |
Transarticular | 2 (-, M, I) | 1 | 35 | ||
Inline | 1 (S, -, -) | Mid-ala | 63 | 1 (S, -, -) | 80% (61-97) |
Inline | 1 (S, -, -) | Mid-sacrum | 61 | ||
Transarticular | 1 (S, -, -) | Mid-ala | 97 | ||
Transarticular | 1 (S, -, -) | Mid-sacrum | 97 | ||
Inline | 1 (-, M, -) | 1 | 78 | 1 (-, M, -) | 92% (78-106) |
Transarticular | 1 (-, M, -) | 1 | 106 | ||
Inline | 1 (-, -, I) | 1 | 93 | 1 (-, -, I) | 104% (93-115) |
Transarticular | 1 (-, -, I) | 1 | 115 |
- Citation: Lindsey DP, Kiapour A, Yerby SA, Goel VK. Sacroiliac joint stability: Finite element analysis of implant number, orientation, and superior implant length. World J Orthop 2018; 9(3): 14-23
- URL: https://www.wjgnet.com/2218-5836/full/v9/i3/14.htm
- DOI: https://dx.doi.org/10.5312/wjo.v9.i3.14